カテゴリ： MarketLine, アメリカ, 企業調査

Teva Pharmaceuticals USA Inc：企業のM&A・事業提携・投資動向

◆英語タイトル：Teva Pharmaceuticals USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード：DATA904C1989
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：235
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD700 ⇒換算￥103,600見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD1,050 ⇒換算￥155,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Teva Pharmaceuticals USA Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Teva Pharmaceuticals USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Teva Pharmaceuticals USA Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Teva Pharmaceuticals USA Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Teva Pharmaceuticals USA Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Teva Pharmaceuticals USA Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Teva Pharmaceuticals USA Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Teva Pharmaceuticals USA Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Teva Pharmaceuticals USA Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
PARTNERSHIP 7
Partnership – Overview 7
Partnership – Deal reports 8
DIVESTMENTS 218
Divestments – Overview 218
Divestments – Deal reports 219
APPENDIX 225
Contact Us 225
About MarketLine Financial Deals Database 225
Deal Definition and Methodology 227
About MarketLine 234

List of Tables
Table 1: Teva Pharmaceuticals USA Inc partnership volume and value trend (2014-YTD2018)
Table 2: Teva Pharmaceuticals USA Inc partnership trend by key deal type (2014-YTD2018)
Table 3: Teva Pharmaceuticals USA Inc divestments volume and value trend (2014-YTD2018)
Table 4: Teva Pharmaceuticals USA Inc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Teva Pharmaceuticals USA Inc partnership volume and value trend (2014-YTD2018)
Figure 2: Teva Pharmaceuticals USA Inc partnership trend by key deal type (2014-YTD2018)
Figure 3: Teva Pharmaceuticals USA Inc divestments volume and value trend (2014-YTD2018)
Figure 4: Teva Pharmaceuticals USA Inc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Teva Pharmaceuticals USA Inc：企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Harte Hanks Inc (HHS)：企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Novartis AG (NOVN)：企業の財務・戦略的SWOT分析
    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Baltimore Gas and Electric Company：発電所・企業SWOT分析
    Baltimore Gas and Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • bet-at-home.com AG (ACX)：企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mercuria Energy Group Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary Mercuria Energy Group Ltd (Mercuria Energy) is an independent energy and commodity company that carries out sourcing, supplying and trading of crude oil and refined petroleum products through its subsidiaries. Its portfolio includes petrochemicals, biofuels, environmental products, natural g …
  • Santen Pharmaceutical Co Ltd (4536)：製薬・医療：M&Aディール及び事業提携情報
    Summary Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, Inflammation and others; OTC …
  • Eletrosul Centrais Eletricas SA：電力：M&Aディール及び事業提携情報
    Summary Eletrosul Centrais Eletricas SA (Eletrosul) is a power generation company. The company’s business activities include generation, transmission, commercialization of energy and telecommunication services. It also invests in research and development of alternative energy sources. Eletrosul’s ge …
  • Commercial Bank International PSC：企業の戦略・SWOT・財務情報
    Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Select Medical Holdings Corporation：企業の戦略・SWOT・財務情報
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Bilfinger SE (GBF)：電力：M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • Global Investment House KPSC (GLOBAL)：企業の財務・戦略的SWOT分析
    Global Investment House KPSC (GLOBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Norfolk Southern Corp (NSC)：企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • PTT Public Company Limited：戦略・SWOT・企業財務分析
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Takara Bio Inc (4974)：企業の財務・戦略的SWOT分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • National Heart Lung and Blood Institute-製薬・医療分野：企業M&A・提携分析
    Summary National Heart Lung and Blood Institute (NHLBI), a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs …
  • Godrej Consumer Products Limited：企業の戦略・SWOT・財務情報
    Godrej Consumer Products Limited - Strategy, SWOT and Corporate Finance Report Summary Godrej Consumer Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Fagron NV (FAGR)：企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), is a pharmaceutical company that provides compounding solutions. The company offers products such as raw materials, flammable products, extracts and tinctures; anesthetic, syrups, ointment bases, medispend, triturations, suspension media, phyto pharmaflore, capsicards sys …
  • Atradius NV：企業の戦略的SWOT分析
    Atradius NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Koei Tecmo Holdings Co Ltd：企業の戦略・SWOT・財務分析
    Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mabuhay Vinyl Corp (MVC)：企業の財務・戦略的SWOT分析
    Mabuhay Vinyl Corp (MVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆